Short Interest in Santhera Pharmaceuticals Holding AG (OTCMKTS:SPHDF) Grows By 700.0%

Santhera Pharmaceuticals Holding AG (OTCMKTS:SPHDF) saw a significant growth in short interest during the month of December. As of December 15th, there was short interest totalling 800 shares, a growth of 700.0% from the November 30th total of 100 shares. Based on an average daily volume of 200 shares, the days-to-cover ratio is currently 4.0 days.

Santhera Pharmaceuticals Stock Performance

SPHDF remained flat at $9.42 during midday trading on Thursday. Santhera Pharmaceuticals has a one year low of $9.42 and a one year high of $9.42. The company has a fifty day moving average of $10.92 and a two-hundred day moving average of $11.43.

Santhera Pharmaceuticals Company Profile

Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company, together with its subsidiaries, develops and commercializes medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the European Union and internationally. The company's lead pipeline candidate includes Vamorolone, which is being developed for the treatments of Duchenne muscular dystrophy (DMD).